SCHEMBL7872523

SCHEMBL7872523

CCOC(=O)C1=C(c2ccc(-c3ccsc3)cc2)NC(C)=C(C(=O)OCC#Cc2cccnc2)C1CCc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 12/20 0.43
TRPV1 Q8NER1 3/20 0.40
TMIGD3 P0DMS9 2/20 0.39
GAA P10253 1/20 0.39
MAPK1 P28482 2/20 0.38
MAPT P10636 1/20 0.38
CYP3A4 P08684 2/20 0.38
ALDH1A1 P00352 2/20 0.37
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7871534 0.94 ADORA3 (0.42) ADORA3TRPV1TMIGD3GAAMAPK1
SCHEMBL7873220 0.88 ADORA3 (0.45) ADORA3TRPV1TMIGD3GAAMAPK1
SCHEMBL7876057 0.85 ADORA3 (0.42) ADORA3TRPV1TMIGD3GAAMAPK1
SCHEMBL7871558 0.84 ADORA3 (0.43) ADORA3TRPV1TMIGD3GAAMAPK1
SCHEMBL7876025 0.84 ALDH1A1 (0.42) ADORA3TRPV1TMIGD3GAAMAPK1
SCHEMBL7871453 0.83 ADORA3 (0.41) ADORA3TRPV1TMIGD3GAAMAPK1
SCHEMBL7873366 0.83 ADORA3 (0.41) ADORA3TRPV1TMIGD3GAAMAPK1
SCHEMBL7873349 0.82 ADORA3 (0.41) ADORA3TRPV1TMIGD3GAAMAPK1
SCHEMBL7864230 0.82 ADORA3 (0.41) ADORA3TRPV1TMIGD3GAAMAPK1
SCHEMBL7873275 0.82 ADORA3 (0.34) ADORA3TMIGD3MAPK1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6306853-B1 DICARBOXYLIC ESTER DERIVATIVES OF DIHYDROPYRIDINE COMPOUNDS NIKKEN CHEMICALS CO., LTD. (JP) 2001-10-23 US disclosed
EP-1055672-A1 1,4-DIHYDROPYRIDINE DERIVATIVES Nikken Chemicals Company, Limited (JP) 2000-11-29 EP disclosed